News
Hetero, a Globally Renowned Vertically Integrated Pharmaceutical Organization, on Friday ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from Phase III clinical trials of Molnupiravir in mild #Covid19 patients conducted across multiple Covid-dedicated hospital sites across #India.'
Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from Phase III clinical trials of Molnupiravir in mild #Covid19 patients conducted across multiple Covid-dedicated hospital sites across #India. pic.twitter.com/NVsWGOMR2t— IANS Tweets (@ians_india) July 9, 2021
(The above story first appeared on LatestLY on Jul 09, 2021 12:30 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
